Page 104 - Read Online

Cacabelos. J Transl Genet Genom 2021;5:133-5 https://dx.doi.org/10.20517/jtgg.2021.07 Page 135

Financial support and sponsorship
None.

Conflicts of interest
No conflicts of interest declared.

Ethical approval and consent to participate
Not applicable.

Consent for publication
Not applicable.

Copyright
© The Author(s) 2021.

REFERENCES
1. Cacabelos R. World Guide for Drug Use and Pharmacogenomics. EuroEspes Publishing Co.; Corunna, 2012.
2. Cacabelos R. Pharmacoepigenetics. Academic Press/Elsevier; San Diego, 2019.
3. Cacabelos R, Cacabelos N, Carril JC. The role of pharmacogenomics in adverse drug reactions. Expert Rev Clin Pharmacol
2019;12:407-42. DOI PubMed
4. Obeng A, El Rouby N, Liu M, Wallsten R. Important preparatory steps and clinical considerations for pharmacogenetics adoption into
practice. J Transl Genet Genom 2020:4. DOI
5. Pandey A, Estepp JH, Ramkrishna D. Hydroxyurea treatment of sickle cell disease: towards a personalized model-based approach. J
Transl Genet Genom 2021:5. DOI
6. Genvigir FDV, Cerda A, Hirata TDC, Hirata MH, Hirata RDC. Mycophenolic acid pharmacogenomics in kidney transplantation. J
Transl Genet Genom 2020;4:320-55. DOI
7. Amadori E, Brolatti N, Scala M, et al. Precision medicine in early-onset epilepsy: the KCNQ2 paradigm. J Transl Genet Genom
2020;4:278-84. DOI
8. Seguí HA, Melin K, Quiñones DS, Duconge J. A review of the pharmacogenomics of buprenorphine for the treatment of opioid use
disorder. J Transl Genet Genom 2020;4:263-77. DOI PubMed PMC
9. Lu DY, Wu HY, Cao S, Che JY. Historical analysis of suicide. J Transl Genet Genom 2020;4:203-9. DOI
10. Cacabelos R. Population-level pharmacogenomics for precision drug development in dementia. Expert Rev Precis Med Drug Dev
2018;3:163-88.